| An analysis of the slowdown in growth of spending for psychiatric drugs, 1986-2008. | |
| | |
MedLine Citation:
|
PMID: 22227754 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: This study analyzed recent trends in spending on psychiatric prescription drugs and underlying factors that served as drivers of these changes. METHODS: Data were collected from the MarketScan Commercial Claims and Encounters Database (1997-2008), Substance Abuse and Mental Health Services Administration spending estimates (1986-2005), and the Medical Expenditure Panel Survey (1997-2007). The trends in medication spending derived from the data were decomposed into three categories: percentage of enrollees who used psychiatric medications, days supplied per user, and cost per day supplied. RESULTS: The average annual rate of growth in expenditures per enrollee slowed from 18.5% in 1997-2001 to 6.3% in 2001-2008. A decline in the growth rate of cost per day supplied, from 8% to 2%, accounted for 49% of the overall decline in spending growth, and a decline in the growth of the percentage of enrollees who used medication, from 7% to 2%, contributed 41% to the overall decline. There was a smaller change in days supplied per user, from 3% to 2%, that contributed 10% to the overall decline. The increased entry of generic medications, which constituted 70% of all psychiatric prescriptions by 2008, particularly generic antidepressants, was a key contributor to the slower growth in costs. CONCLUSIONS: Past high growth in psychiatric drug spending arising from growth in utilization of branded medications has declined significantly, which may have implications for access and new product investment. |
| | |
Authors:
|
Tami L Mark; Cheryl Kassed; Katharine Levit; Rita Vandivort-Warren |
Related Documents
:
|
21851564 - Recommended responses to lapses in professionalism. 21982134 - Complementary medicine use is not associated with non-adherence to conventional medicat... 4005614 - Presence of retinogeniculate fibers is essential for initiating the formation of each i... 21107504 - Emergency medical coordination using a web platform: a pilot study. 19700884 - Mefenamic acid-induced bilateral transient myopia, secondary angle closure glaucoma and... 10628004 - Piloting the institute of medical illustrators and glasgow caledonian university bsc in... |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Psychiatric services (Washington, D.C.) Volume: 63 ISSN: 1557-9700 ISO Abbreviation: Psychiatr Serv Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-01-09 Completed Date: 2012-05-04 Revised Date: 2012-05-14 |
Medline Journal Info:
|
Nlm Unique ID: 9502838 Medline TA: Psychiatr Serv Country: United States |
Other Details:
|
Languages: eng Pagination: 13-8 Citation Subset: IM |
Affiliation:
|
Thomson Reuters, 4301 Connecticut Ave., NW, Washington, DC 20008, USA. tami.mark@thomsonreuters.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Drug Costs
/
trends Drug Prescriptions / statistics & numerical data Drug Utilization / trends* Drugs, Generic / economics Health Care Surveys Health Expenditures / trends* Humans Mental Disorders / drug therapy* Prescription Drugs / economics Psychotropic Drugs / economics* United States |
| Grant Support | |
ID/Acronym/Agency:
|
HHS-270-2006-000 23C//PHS HHS |
| Chemical | |
Reg. No./Substance:
|
0/Drugs, Generic; 0/Prescription Drugs; 0/Psychotropic Drugs |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Best practices: recovery centers for people with a mental illness: an emerging best practice?
Next Document: Perceptions of the state policy environment and adoption of medications in the treatment of substanc...